← See Pat Ryan's full record
H.R.4691 Iran Sanctions Relief Review Act
Restricts the president's ability to waive Iran sanctions, requiring 30-60 day congressional review of any relief (118th Congress)
View on Congress.govLegal & Constitutional Grounding
Restricting waivers under IEEPA limits diplomacy; sanctions caused 6M+ patient shortages, 6x thalassemia deaths (Lancet/HRW).
International Emergency Economic Powers Act (IEEPA), 50 U.S.C. § 1701 et seq. — presidential authority to impose and waive economic sanctions
- CISADA, 22 U.S.C. § 8501 et seq.
- HRW 'Maximum Pressure' (Oct. 2019) — 6M+ patients affected; Factor VIII access for hemophilia patients dropped from 96.7% to 3.3% (2009-2012)
- WHO EMRO — 13 of 26 essential NCD medicines had significantly reduced availability; antiepileptic drug prices spiked 300%
- Lancet (2025) — thalassemia patient life expectancy dropped from 50 years to under 20; deaths increased sixfold (2018-2022)
- CEPR/Rodriguez (2023) — 30 of 32 studies found negative effects; sanctions cause average 1.4-year reduction in female life expectancy
Restricts presidential authority to waive Iran sanctions, requiring congressional review. Limiting diplomatic flexibility undermines ongoing negotiations and the executive's ability to pursue de-escalation.